Skip to main content
Type
Journal Article
Title

How many billions is enough? Prioritizing profits over patients with cystic fibrosis

Authors:

Author Name(s)
Meghan E. McGarry
Elizabeth R. Gibb
Theresa A. Laguna
Brian P. O'Sullivan
Gregory S. Sawicki
Jeffery T. Zobell

Year:

Date
2023
Journal Book Publisher Name
Pediatric Pulmonology

Description

Description

McGarry and colleagues criticize Vertex pharmaceuticals, the sole manufacturer of cystic fibrosis transmembrane conductance regulator (CFTR) modulators, for drastically decreasing its copayment assistance programs and call for specific measures to protect access to life-changing medications for CF patients.

Share